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Toxoplasma  gondii  causes  life-threatening  toxo-
plasmosis  in  immunocompromised  individuals 
such  as  those  suffering  from AIDS  or  being 
treated  by  chemotherapy  (Montoya  and 
Remington, 2008). As a member of the phylum 
of Apicomplexa, T. gondii is an obligate intra-
cellular parasite, defined by the presence of an 
apical  complex  including  secretory  organelles 
such as rhoptries and micronemes (Joynson and 
Wreghitt, 2001). During invasion, T. gondii deli-
vers numerous effector molecules into the form-
ing parasitophorous vacuole (PV) and the host 
cytoplasm to co-opt the host cell for growth and 
survival (Boothroyd and Dubremetz, 2008).
T. gondii is divided into three major line-
ages (types I, II, and III) in addition to exotic 
strains (Ajzenberg et al., 2004; Dardé, 2008). 
Although type II parasites are the most prevail-
ing opportunistic strains, infection with type I 
strains appears to be responsible for encephalitis 
in AIDS patients, ocular toxoplasmosis, and con-
genital  hydrocephalus,  whereas  infection  with 
type III strains seldom results in disease manifesta-
tions (Howe and Sibley, 1995; Boothroyd and 
Grigg, 2002). In terms of the strain-dependent 
phenotypes, virulence in mice  has  been  well 
characterized, although the median lethal dose 
of type II or III parasites ranges from 102 to 
105, and the lethal dose of the most virulent 
type I strain is one (100) parasite (Sibley and 
Boothroyd,  1992;  Sibley  and  Howe,  1996; 
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The ROP18 kinase has been identified as a key virulence determinant conferring a high 
mortality phenotype characteristic of type I Toxoplasma gondii strains. This major effector 
molecule is secreted by the rhoptries into the host cells during invasion; however, the 
molecular mechanisms by which this kinase exerts its pathogenic action remain poorly 
understood. In this study, we show that ROP18 targets the host endoplasmic reticulum–
bound transcription factor ATF6. Disruption of the ROP18 gene severely impairs acute 
toxoplasmosis by the type I RH strain. Because another virulence factor ROP16 kinase 
modulates immune responses through its N-terminal portion, we focus on the role of the  
N terminus of ROP18 in the subversion of host cellular functions. The N-terminal extension 
of ROP18 contributes to ATF6-dependent pathogenicity by interacting with ATF6 and 
destabilizing it. The kinase activity of ROP18 is essential for proteasome-dependent degra-
dation of ATF6 and for parasite virulence. Consistent with a key role for ATF6 in resis-
tance against this intracellular pathogen, ATF6-deficient mice exhibit a high susceptibility 
to infection by ROP18-deficient parasites. The results reveal that interference with ATF6-
dependent immune responses is a novel pathogenic mechanism induced by ROP18.
© 2011 Yamamoto et al.  This article is distributed under the terms of an At-
tribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months after the publication date (see http://www.rupress.org/terms). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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Taylor et al., 2006; Dubremetz, 2007). Most recently, ROP18 
has been shown to target a member of IFN-inducible small 
GTPases (immunity-related GTPases [IRGs]), Irgb6 (Fentress 
et al., 2010; Steinfeldt et al., 2010), indicating that interference 
with the innate function of Irgb6 is a key mechanism by 
which ROP18 mediates virulence at an early stage after 
infection. ROP16, another ROP2 subfamily member, was 
previously identified as virulence determinant, distinguishing 
how type I/III and II strains activate Stat3/6 during parasite 
Dubremetz, 2007). Previous forward genetic studies, in which 
types I/II and III were intercrossed to explore genes responsi-
ble for virulence, culminated in the identification of ROP18 
as the dominant candidate gene (Saeij et al., 2006; Taylor   
et al., 2006).
ROP18 is a Ser/Thr kinase related to the ROP2 sub-
family, secreted by the rhoptries into the PV and host cytosol. 
Its action as effector molecule is anticipated to modulate host 
factors by an as yet unknown mechanism (El Hajj et al., 2006; 
Figure 1.  The N terminus of ROP18 is required for acute virulence in type I T. gondii. (A) The structure of the ROP18 gene, the targeting vector, 
and the predicted disrupted gene. Closed boxes denote the exons. (B) Southern blot analysis of WT or two lines of rop18-KO parasites. 30 µg total ge-
nomic DNA was extracted from parasites, digested with BglII–BamHI, electrophoresed, and hybridized with the radiolabeled probe indicated in A. South-
ern blotting yielded a single 6.6-kb band for the WT and a 3.7-kb band for the disrupted locus. (C) Northern blot analysis on 10 µg total parasite RNA 
separated on a gel, transferred to a nylon membrane, and hybridized with ROP18 probe. The 28S and 18S ribosomal RNA is shown as the loading control 
(bottom). (D) BALB/c mice (n = 10) were infected with 103 WT or rop18-KO parasites, and the survival rates were monitored for 20 d. (E) BALB/c mice (n = 4) 
were infected with 103 WT or rop18-KO luciferase-expressing parasites, and the progress of infection was assessed by bioluminescence imaging at day 6 
after infection. The color scale indicates photon emission during a 60-s exposure. (F) Total photon emission analysis from BALB/c mice (n = 4) infected 
with 103 WT or rop18-KO luciferase-expressing parasites at days 3, 5, or 7 after infection. Abdominal photon emission was assessed during a 60-s expo-
sure. The red bars show means of the four samples. *, P < 0.05; **, P < 0.001. (G) BALB/c mice (n = 8) were infected with 103 rop18-KO parasites comple-
mented with the indicated vectors, and the survival rates were monitored for 20 d. (B–G) Data are representative of two independent (B, C, E, and F) or 
cumulative percentages of two independent (D and G) experiments.JEM Vol. 208, No. 7 
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(Fig. S2, A and B). Expression of ROP18_F fully restored 
acute virulence, whereas the Empty vector parasites exhibited an 
avirulent phenotype comparable with the parental rop18-KO 
parasites. The recovery of the virulence in N2-ROP18 
parasites was only partial compared with the ROP18_F strain 
(Fig. 1 G). These data formally establish that ROP18 is a 
virulence factor of acute toxoplasmosis in type I strain and 
highlight the important contribution of the N-terminal 
extension  of  ROP18  for  the  full  manifestation  of  the   
virulence phenotype.
Enhanced type I immune responses in mice infected  
with rop18-KO parasites
We next compared type I immune responses in the infected 
BALB/c mice because IFN-, mainly produced by Th1-
polarized CD4 and CD8 T cells, plays a critical role in the 
control of acute toxoplasmosis (Subauste and Remington, 
1991; Shirahata et al., 1994; Yap and Sher, 1999). 6 d after 
infection, CD4 and CD8 T cells from the spleens of mice 
demonstrating no abnormalities in appearance and no alter-
ation in splenic cellularities and were tested for IFN- pro-
duction by anti-CD3 treatment (Fig. S3, A–C). Compared 
with T cells from mice infected with WT parasites, CD4 
and CD8 T cells from those infected with rop18-KO para-
sites displayed dramatically higher IFN- production in 
response to anti-CD3 (Fig. 2, A and B). To analyze antigen-
specific IFN- production, we next compared the produc-
tion from T cells stimulated with heat-killed T. gondii in the 
presence  of  DCs.  Even  in  this  condition,  CD4  and  CD8   
T cells from mice infected with rop18-KO parasites pro-
duced higher concentrations of IFN- than those infected 
with WT parasites (Fig. 2, A and B). Collectively, these re-
sults show that ROP18 critically contributes to the suppres-
sion of the host type I immunity during infection with the 
virulent type I strain.
infection (Saeij et al., 2006, 2007). Subsequently, this effector 
molecule  was  shown  to  directly  phosphorylate  Stat3  and 
Stat6, and the N-terminal extension of ROP16 was demon-
strated to play a key role in the interaction with the substrates 
(Yamamoto et al., 2009; Ogawa et al., 2010; Ong et al., 
2010). Like ROP16, ROP18 exhibits an uncharacterized   
N-terminal extension (El Hajj et al., 2006).
To explore the function of the N terminus of ROP18, 
we first generated ROP18-deficient type I parasites and con-
firmed the in vivo significance of ROP18 in the type I para-
site–mediated virulence. Complementation experiments showed 
that the N-terminal portion of ROP18 is required for the full 
recovery of virulence in rop18-KO parasites. A yeast two-hybrid 
screening and biochemical experiments found that the host 
factor ATF6 is a binding partner with the N-terminal ex-
tension  of  ROP18. This  association  led  to  a  proteasome-
  dependent degradation of ATF6 in a kinase activity–dependent 
manner.  Consistent  with  a  defensive  function  of  ATF6 
against the parasite, ATF6-deficient mice were generated 
and shown to be highly susceptible to rop18-KO but not WT 
parasites. Collectively, these results identified ATF6 as one 
of the host cellular factors targeted by ROP18 in the context 
of acute pathogenesis by the type I T. gondii strain.
RESULTS
The N terminus of ROP18 is involved in acute virulence  
in type I parasites
To determine whether ROP18 contributes to the high mor-
tality rate of type I strains in mice, we disrupted the ROP18 
gene in the type I RH strain by reverse genetics and isolated 
several independent clones (Fig. 1, A and B). Northern blot 
analysis confirmed the absence of ROP18 messenger RNAs 
in the clones (Fig. 1 C). The parasite lytic cycle as measured 
by plaque assay and intracellular growth on human foreskin 
fibroblasts (HFFs) was unaffected in these mutants as com-
pared with WT parasites (Fig. S1, A and B). The recruitment 
of host organelles such as the mitochondria and ER around 
the PV was unaltered (unpublished data). We first challenged 
BALB/c mice with WT or rop18-KO parasites and moni-
tored animal survival for 20 d. All mice infected with WT 
parasites died within 9 d. In contrast, mice infected with 
rop18-KO parasites showed a considerably lower mortality 
rate (Fig. 1 D). Luciferase-expressing WT or rop18-KO para-
sites were generated to visualize the in vivo parasite burden 
in BALB/c mice. A significantly stronger signal was detected 
in the ventral side of mice infected with WT parasites than 
those with rop18-KO parasites (Fig. 1 E). Moreover, the pho-
ton  flux  measurement  during  the  course  of  infection  in-
creased notably faster and demonstrated a two log difference 
between WT and rop18-KO parasites at 7 d after infection 
(Fig. 1 F). Given the importance of the N-terminal extension 
for ROP16, we complemented rop18-KO parasites with full-
length Flag-tagged (F) ROP18 (ROP18_F strain), the ROP18 
mutant deleted in residues 147–164 of the N-terminal portion 
(N2-ROP18_F strain), or the empty vector (Empty vector strain) 
and tested the recovery of the acute virulence phenotype 
Figure 2.  Enhanced IFN- production from T cells in mice in-
fected with rop18-KO parasites. (A and B) CD4 (A) or CD8 (B) T cells 
from BALB/c (n = 3) mice were cultured in the presence of 5 µg/ml plate-
bound anti-CD3 for 24 h or in the presence or absence of T. gondii anti-
gen–pulsed BMDCs for 24 h. Concentration of IFN- in the culture 
supernatants was measured by ELISA. Indicated values are means ± SD of 
triplicates. Data are representative of three independent experiments. ND, 
not detected.1536 ATF6 is a host target of Toxoplasma ROP18 | Yamamoto et al.
(HA)-tagged ATF6 in mammalian 293T cells. Interestingly, 
we failed to detect an interaction between 27-ROP18_F 
and  HA-ATF6,  but  we  noticed  that  overexpression  of 
27-ROP18_F but not 240-ROP18_F resulted in a dra-
matic reduction in the level of HA-ATF6 (Fig. 3 B). To 
determine whether parasite infection also caused a drop in 
HA-ATF6 levels, 293T cells expressing HA-ATF6 fused 
to CFP (with a self-cleavage signal [T2A] in between to 
produce the same level of both proteins) were similarly in-
fected with WT or rop18-KO parasites (Fig. S4 B). The level 
of ATF6 protein was consistently reduced in cells infected 
with WT but not with rop18-KO parasites (Fig. 3 C). More-
over,  27-ROP18_F  but  not  240-ROP18_F  decreased 
the ATF6  level  in  a  dose-dependent  fashion  in  dually 
transfected 293T cells (Fig. 3 D). ATF6 is a component of 
the ER stress response transcription factor that activates ex-
pression of genes harboring an unfolded protein response 
ROP18 interacts with ATF6 and mediates its degradation
The N-terminal extension of ROP16 interacts with the 
host  factors  Stat3/Stat6  (Yamamoto  et  al.,  2009;  Ogawa   
et al., 2010). Therefore, a yeast two-hybrid screening was 
undertaken to identify potential host partners interacting 
with  the  N-terminal  portion  of  ROP18  (Nt-ROP18). 
ATF6, a component of the ER membrane–bound tran-
scription factor implicated in stress response, was found as 
the predominant hit, and its association with Nt-ROP18 
was  first  confirmed  in  yeast  cells  (Fig.  3 A).  Moreover,   
Nt-ROP18 and ATF6 failed to interact with SV40 large   
T antigen and p53 used as negative controls, respectively, demon-
strating that Nt-ROP18 specifically associates with ATF6 
in yeast (Fig. S4 A). To further assess the specificity of this 
interaction,  we  expressed  Flag-tagged  ROP18  lacking  its 
signal peptide (27-ROP18_F) or a larger N-terminal deletion 
of ROP18 (240-ROP18_F) together with hemagglutinin 
Figure 3.  Identification of ATF6 as a ROP18-
interacting protein. (A) Plasmids expressing Nt-
ROP18 fused to the GAL4 DNA-binding domain or an 
empty vector were cotransfected with a plasmid ex-
pressing ATF6 fused to the GAL4 transactivation 
domain or an empty vector. Interactions were de-
tected by the ability of cells to grow on medium lack-
ing Ade, Trp, Leu, and His (-L-W-A-H). Growth of cells 
on plates lacking Trp and Leu (-L-W) was indicative of 
the efficiency of the transfection. (B) Lysates of 293T 
cells transiently cotransfected with 2 µg of the indi-
cated Flag-tagged ROP18 and/or 2 µg HA-tagged 
ATF6 expression vectors were immunoprecipitated 
with the indicated antibodies and detected by West-
ern blot with the indicated antibodies. The top images 
denote the structure of ROP18 variants used in this 
study. WT, original ROP18; SP, signal peptide; Y2H, 
the region used as the bait in the yeast two-hybrid 
screen. (C) The 293T cells transfected with 0.1 µg 
plasmids for tandem expression of HA-tagged ATF6 
and T2A-CFP were infected with the indicated para-
sites at an MOI of 10. 24 h after infection, the cells 
were lysed and subjected to Western blot or immuno-
precipitation (IP) with anti-HA (left). The expression 
levels of HA proteins were normalized against CFP 
(right). Error bars represent means ± the variation 
range of duplicates. IB, immunoblot; WCL, whole cell 
lysates. (D) Lysates of 293T cells transiently cotrans-
fected with the indicated volumes of the Flag-tagged 
27- or 240-ROP18 and/or 2 µg HA-tagged ATF6 
expression vectors were immunoprecipitated with the 
indicated antibodies and detected by Western blot 
with the indicated antibodies. (E) 293T cells were 
transfected with the ATF6-dependent luciferase 
reporter together with the indicated expression vec-
tors. Luciferase activities were expressed as fold in-
creases over the background levels shown by lysates 
prepared from mock-transfected cells. Error bars 
represent means ± SD of triplicates. (F) Lysates of 
293T cells transiently cotransfected with 2 µg Flag-tagged ROP18 and/or 2 µg HA-tagged ATF6 expression vectors in the absence or presence of 10 µM 
MG132 for the last 12 h were immunoprecipitated with the indicated antibodies and detected by Western blot. (A–F) Data are representative of three  
(B and D–F) and two (A and C) independent experiments.JEM Vol. 208, No. 7 
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The kinase activity of ROP18 is required  
for ATF6 degradation
ROP18 was previously shown to be a secreted active protein 
kinase in vitro and in vivo (Taylor et al., 2006; El Hajj et al., 
2007). To assess whether the kinase activity of ROP18 plays 
a role in type I parasite–mediated pathogenicity, we comple-
mented  the  rop18-KO  parasites  with  WT  (ROP18_F)  or   
kinase-dead (KD; KD-ROP18_F) constructs (Fig. S2, B and 
C) and tested the virulence of the corresponding parasites in 
BALB/c mice (Fig. 4 A). Mice infected with ROP18_F re-
sulted in 100% lethality within 10 d. In contrast, most of mice 
infected with KD-ROP18_F survived throughout the tested 
period. These results are consistent with a previous study, 
which reported that an avirulent type III strain expressing the 
ROP18 but not the KD form of the type I strain can acquire 
virulence, pointing out the essential role of kinase activity of 
ROP18 for acute virulence (Taylor et al., 
2006).  To  determine  whether  the  kinase 
activity is involved in the ROP18-mediated 
degradation of ATF6, mammalian expres-
sion vectors for KD-ROP18_F, ATF6, and 
UPRE-containing luciferase reporter were 
cotransfected into 293T cells and followed 
by luciferase assays (Fig. 4 B). Overexpression 
of KD-ROP18_F failed to suppress ATF6-
mediated  gene  activation.  Moreover,  the 
(UPR) element (UPRE) in their promoters (Wang et al., 
2000; Yoshida et al., 2001). Overexpression of HA-ATF6 
resulted in the activation of a UPRE-containing luciferase 
reporter in 293T cells; however, the coexpression of 27-
ROP18_F  but  not  240-ROP18_F  down-regulated  the 
ATF6-dependent activation in a dose-dependent manner 
(Fig. 3 E). To determine whether the ROP18-dependent 
decrease in ATF6 protein level is mediated by the protea-
some, HA-ATF6 was coexpressed with 27-ROP18_F 
in the presence of the proteasome inhibitor MG132. Under 
this condition, the level of ATF6 was stabilized, and the 
interaction  between  27-ROP18  and ATF6  could  be 
monitored by coimmunoprecipitation (Fig. 3 F). Together, 
these data support the view that ROP18 associates with 
ATF6 and targets it to a proteasome-dependent degrada-
tion pathway.
Figure 4.  Essential role of ROP18 kinase activ-
ity in ATF6 degradation. (A) BALB/c mice (n = 8) 
were infected with 103 rop18-KO parasites comple-
mented with the indicated vectors, and the survival 
rates were monitored for 20 d. (B) 293T cells were 
transfected with the ATF6-dependent luciferase 
reporter together with the indicated expression vec-
tors. Luciferase activities were expressed as fold in-
creases over the background levels as shown by 
lysates prepared from mock-transfected cells. Error 
bars represent means ± SD of triplicates.  
(C and D) Lysates of 293T cells transiently cotrans-
fected with 2 µg of the indicated Flag-tagged ROP18 
and/or 2 µg of HA-tagged ATF6 expression vectors 
were immunoprecipitated with the indicated anti-
bodies and detected by Western blot. (E and F) 293T 
cells were transiently transfected with Flag-tagged 
ROP18WT, ROP18KD, or ROP16WT. Cell lysates were 
immunoprecipitated with anti-Flag and subjected to 
an in vitro kinase reaction in the presence of GST–
ATF6. Proteins were separated on SDS-PAGE, fol-
lowed by autoradiography (E) or Western blot (F) to 
analyze ATF6 phosphorylation or the autophos-
phorylation of ROP18 and ROP16. For the detection 
of phosphorylated or unphosphorylated GST-ATF6 
and Flag-tagged proteins by Western blot, anti-
pThr/anti-pTyr, anti-GST, and anti-Flag were used, 
respectively. IB, immunoblot; IP, immunoprecipitation.   
(A–F) Data are representative of three (B) or two  
(A and C–F) independent experiments.1538 ATF6 is a host target of Toxoplasma ROP18 | Yamamoto et al.
is implicated in the association with ROP18. Intriguingly, the 
family members of ATF6 proteins are anchored in the mem-
brane of the ER with their C-terminal region predicted to local-
ize in the lumen (Stirling and O’Hare, 2006). If this topology 
holds true for ATF6, it would imply that ROP18 needs to gain 
access to ATF6 in the host ER. To examine whether ROP18 
localizes to the ER, YFP-tagged ATF6 and T2A_CFP-tagged 
KD-ROP18 were bicistronically cloned and coexpressed with 
an ER-localized RFP in 293T cells (Fig. S5, A and B). Live 
microscopy revealed colocalization of ER-localized RFP and 
CFP-ROP18, suggesting that ROP18 is in close proximity with 
ER-resident proteins. The host ER has recently been reported 
to fuse with the PV membrane (PVM; Sinai et al., 1997;   
Goldszmid et al., 2009), and thus it is plausible that ER-localized 
ATF6  in  the  vicinity  of  PVMs  might  be  targeted  by 
ROP18. Indeed, when HFFs infected with parasites were 
analyzed by electron microscopy, PVMs not only associated 
with, but also appeared to directly fuse with the host ER 
(Fig. S5 C). These results indicate that the functional ROP18 
kinase is necessary to trigger degradation of ATF6 and sug-
gest that ROP18 might colocalize with ATF6 in the host 
ER or at the PVM.
Defensive function of ATF6 against infection  
of rop18-KO parasites
Given the correlation between the ability of ROP18 to in-
duce ATF6 degradation and manifestation of virulence in 
type  I  parasites,  we  hypothesized  that  mice  infected  with 
rop18-KO parasites are resistant, at least in part, because of a 
protective effect dependent on ATF6. To test this possi-
bility under physiological conditions, we generated mice 
lacking the Atf6 gene (Fig. S6, A–C). Homozygous mice 
with  the  Atf6-deleted  allele  were  born  at  the  expected 
Mendelian ratio and grew healthy in specific pathogen–free   
conditions, as previously reported for another line of ATF6-
deficient mice (Yamamoto et al., 2007). In terms of the cellular-
ity of immune cells   
under unstimulated   
conditions, ATF6- 
deficient  mice  be-
haved  similarly  to 
WT mice (unpub-
lished data). When 
ectopic expression of ROP18_F but not KD-ROP18_F led 
to HA-ATF6 degradation. KD-ROP18_F coprecipitated 
with  ATF6,  as  previously  observed  in  the  presence  of 
MG132 (Figs. 3 F and 4 C). These results establish a connec-
tion between the kinase activity of ROP18 and ATF6 deg-
radation. To examine which portion of the N terminus of 
ROP18 interacts with ATF6, vectors expressing the KD ver-
sions 27- or 240-ROP18_F were introduced into 293T 
cells together with ATF6. HA-ATF6 coprecipitated with 
27-KD-ROP18_F  but  not  with  240-KD-ROP18_F 
(Fig. 4 C). To refine the analysis, 27N2-ROP18_F was 
cotransfected and shown to fail to coprecipitate with ATF6 
(Fig. 4 D), indicating that the N-terminal 147–164 portion of 
ROP18 determines the binding to ATF6. To challenge the 
possibility that ATF6 is a substrate for ROP18, we per-
formed an in vitro kinase assay using recombinant glutathione 
S-transferase (GST)–tagged ATF6 as a substrate. Immunopre-
cipitates from 293T cells expressing Flag-tagged ROP18WT, 
ROP18KD, or ROP16WT were incubated with GST-ATF6 
in the presence of radiolabeled ATP. Phosphorylation of GST-
tagged ATF6 was detectable in the presence of ROP18WT 
but not with ROP18KD or ROP16WT (Fig. 4 E). To deter-
mine which amino acids on ATF6 are phosphorylated by 
ROP18, we relied on anti–phospho-Thr (anti-pThr), anti–
pSer, and anti–pTyr. GST-tagged ATF6 was detected only 
in  the  presence  of  ROP18WT  with  anti-pThr,  whereas 
anti-pSer and anti-pTyr gave no signal (Fig. 4 F and not de-
picted). In  contrast,  anti-pTyr  detected  autophosphoryla-
tion of ROP16WT (Fig. 4 F), correlating with the Tyr kinase 
activity of ROP16 (Yamamoto et al., 2009; Ong et al., 2010). 
Collectively, these results show that ROP18 phosphorylates at 
least one Thr residue on ATF6, which leads to its degradation.
The C-terminal portion of ATF6 associates with ROP18
To characterize the region on ATF6 implicated in binding 
to ROP18, deletion mutants of ATF6 lacking both the 
transmembrane and the C-terminal portion (CTM) or the 
C terminus alone (C) were generated (Fig. 5 A). Activation 
of the UPRE-containing reporter by CTM-ATF6 was 
unaffected by the presence of ROP18_F, even at high doses 
(Fig. 5 B). Moreover, KD-ROP18_F coprecipitated with 
the HA-tagged full-length ATF6 but not with the C form 
(Fig. 5 C), suggesting that the C-terminal portion of ATF6 
Figure 5.  The C-terminal portion of 
ATF6 interacts with ROP18. (A) HA-
tagged ATF6 variants. bZIP, basic Leu zipper; 
TM, transmembrane. (B) 293T cells were trans-
fected with the ATF6-dependent luciferase 
reporter together with the indicated expres-
sion vectors. Luciferase activities were ex-
pressed as fold increases over the background 
levels as shown by lysates prepared from 
mock-transfected cells. Error bars represent 
means ± the variation range of duplicates.  
*, P < 0.03; **, P < 0.001. (C) Lysates of 293T cells 
transiently cotransfected with 2 µg of the 
indicated Flag-tagged ROP18 and/or 2 µg of 
the indicated HA-tagged ATF6 expression 
vectors were immunoprecipitated with the 
indicated antibodies and detected by Western 
blot. IB, immunoblot; IP, immunoprecipitation. 
(B and C) Data are representative of three (C) 
or two (B) independent experiments.JEM Vol. 208, No. 7 
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CD4 T cells (Fig. 6 D). Next, we examined whether the de-
fective IFN- production from ATF6-deficient cells is in-
trinsic or extrinsic to CD8 T cells. WT DCs were infected 
with irradiated rop18-KO parasites in vitro, and then intra-
peritoneally injected into WT or ATF6-deficient mice. 6 d 
after the injection, splenic CD4 and CD8 T cells were isolated 
and co-cultured with WT DCs noninfected or infected with 
rop18-KO parasites, and the supernatants were analyzed for 
IFN- production. Comparable IFN- production was ob-
served in WT and ATF6-deficient CD8 T cells, suggesting 
that  the  defective  IFN-  production  in ATF6-deficient 
CD8 T cells may be extrinsic to the T cells (Fig. 6 E). Next,   
to test whether APCs determine the phenotype, we col-
lected splenic T cells from WT mice infected with rop18-KO  
parasites 6 d after infection and co-cultured with WT or 
ATF6-deficient DCs noninfected or infected with rop18-KO 
parasites.  We found that CD8  T cells with the infected ATF6-
deficient DCs produced significantly lower amounts of IFN- 
than those with WT DCs (Fig. 6 F). Thus, ATF6 in DCs is 
responsible for the CD8 T cell–mediated host defense against 
rop18-KO parasites.
challenged  with  parasites,  ATF6-deficient  mice  were 
more susceptible to rop18-KO parasites than WT mice (Fig. 6 A). 
In sharp contrast, the susceptibility of both genotypes of 
mice infected with WT parasites was comparable (Fig. S6 D). 
Moreover, ATF6-deficient mice similarly succumbed to in-
fection with complemented rop18-KO parasite lines (Fig. S6 E). 
The CTG strain was used as a natural rop18-KO parasite and 
shown to cause a higher mortality rate in ATF6-deficient 
mice than in WT mice (Fig. S6 F). To follow more accurately 
the course of infection, WT and ATF6-deficient mice were 
infected  with  103  luciferase-expressing  rop18-KO  parasites, 
and the kinetics of infection were monitored by in vivo imag-
ing. Marked increments of rop18-KO parasites were observed 
at days 5, 7, and 8 in ATF6-deficient mice compared with 
WT mice (Fig. 6, B and C). To assess whether type I immune 
responses in ATF6-deficient mice were affected, the T cell 
responses were examined at day 6 after infection with rop18-KO 
parasites. The cellularities after the parasite challenges were 
unchanged in WT and ATF6-deficient mice (unpublished 
data). Under these conditions, a significantly reduced IFN- 
response to anti-CD3 was observed in CD8 T cells but not in 
Figure 6.  ATF6 functions as a host-
defensive protein against rop18-KO para-
sites. (A) WT (n = 14) or ATF6-deficient  
(n = 14) mice were infected with 103 rop18-KO 
parasites, and the survival rates were moni-
tored for 20 d. (B) Total photon emission analy-
sis from WT or ATF6-deficient mice (n = 4) 
infected with 103 rop18-KO luciferase-express-
ing parasites at days 3, 5, or 7 after infection. 
Abdominal photon emission was assessed dur-
ing a 60-s exposure. The red bars show means 
of the four samples. *, P < 0.05. (C) WT or 
ATF6-deficient mice (n = 4) were infected 
with 103 rop18-KO luciferase-expressing para-
sites, and the progress of the infection was 
assessed by bioluminescence imaging at day 8 
after infection. Color scales indicate photon 
emission during a 60-s exposure. (D) CD4 or 
CD8 T cells from WT or ATF6-deficient mice 
(n = 4) were cultured in the presence of 5 µg/ml 
plate-bound anti-CD3 for 24 h. (E) WT DCs 
infected with irradiated rop18-KO parasites 
were injected into WT or ATF6-deficient mice. 
6 d after DC injection, CD4 or CD8 T cells puri-
fied from the spleens were restimulated with 
DCs uninfected or infected with rop18-KO 
parasites for 48 h. (F) CD4 or CD8 T cells puri-
fied from WT mice infected with rop18-KO 
parasites 6 d after infection were restimulated 
with WT or ATF6-deficient DCs uninfected or 
infected with rop18-KO parasites for 48 h.  
(D–F) Concentration of IFN- in the culture 
supernatants was measured by ELISA. Indicated 
values are means ± SD of triplicates. *, P < 0.05. 
ND, not detected. (A–F) Data are representative 
of two (B–F) or a cumulative percentage of 
three (A) independent experiments.1540 ATF6 is a host target of Toxoplasma ROP18 | Yamamoto et al.
cavities and IFN- production from splenic T cells were ex-
amined. Although the parasite number in mice infected with 
Empty vector was less than those in mice with ROP18_F  
or N2-ROP18_F parasites at day 3 after infection, it was 
  almost comparable at day 6. In contrast, the number of para-
sites in mice infected with KD-ROP18_F was consistently 
lower throughout the course of the experiment (Fig. 7 C). In 
terms of IFN- production, although the CD8 T cell–mediated 
production was unaltered, the production from CD4 T cells 
in  mice  infected  with  ROP18_F  or  N2-ROP18_F  was 
markedly reduced compared with that in mice with KD-
ROP18_F or Empty vector (Fig. 7 D). Thus, these results sug-
gest that the ATF6-independent response regulates CD4   
T cell–mediated IFN- production against rop18-KO parasites.
DISCUSSION
In this study, we provide the first genetic and biochemical evi-
dence that the host cellular protein, ATF6, is targeted for deg-
radation by ROP18, a key virulence factor in T. gondii. ATF6 
is a member of the ATF6-related family of transcription factors 
that have been shown to operate in the UPR (Yoshida et al., 
2001;  Yamamoto et al., 2007). Recently, UPR-related molecules 
such as XBP-1 in Caenorhabditis elegans or mammals and a plant 
ATF6-related mole-
cule were shown to 
be involved in host 
ATF6-independent response to the parasite infection
N2-ROP18_F, which are insensitive to the ATF6-mediated 
host response, moderately restored in vivo virulence (Fig. 1 G), 
suggesting that ATF6-independent host responses may be 
functional to eliminate the parasites. Because ROP18 is shown 
to inactivate IRGs by the direct Thr phosphorylation (Fentress 
et al., 2010; Steinfeldt et al., 2010), we postulated the in-
volvement of IRGs in the moderate host resistance in WT 
mice infected with N2-ROP18_F. To assess whether N2-
ROP18 inactivates IRG, macrophages treated with IFN- 
were infected with ROP18_F, N2-ROP18_F, KD-ROP18_F, 
or EMPTY parasites, and the interaction of an IRG Irgb6 
with  the  ROP18  variants  was  examined  by  an  immuno-
precipitation  assay  (Fig.  7  A).  N2-ROP18_F  as  well  as 
ROP18_F and KD-ROP18_F associated with Irgb6 in in-
flammatory macrophages. Next, we tested whether N2-
ROP18 mediates Thr phosphorylation on Irgb6 by an in vitro 
kinase assay. Immunoprecipitates of parasites expressing 
N2-ROP18_F and ROP18_F but not KD-ROP18_F in-
duced Thr phosphorylation of Myc-Irgb6-YFP but not Myc-
YFP (Fig. 7 B and not depicted), indicating that activity of 
the IRG can be blocked by N2-ROP18. Finally, to more 
carefully dissect contribution of the ATF6-independent host 
response, ATF6-deficient mice were infected with rop18-KO 
parasites complemented with ROP18 variants at a low dose 
(102 tachyzoites), and the parasite loads in the peritoneal 
Figure 7.  Parasite-induced ATF6-
  independent host response. (A) Peritoneal 
macrophages treated with 30 ng/ml IFN- for 
24 h were infected with the indicated para-
sites. Lysates of the infected cells were immuno-
precipitated with anti-Flag and detected by 
Western blot with the indicated antibodies.  
IB, immunoblot; IP, immunoprecipitation; WCL, 
whole cell lysate. (B) 293T cells were tran-
siently transfected with empty or Myc-tagged 
Irgb6-YFP vectors. Cell lysates were immuno-
precipitated with anti-Myc and subjected to 
an in vitro kinase reaction in the presence of 
anti-Flag immunoprecipitates of the indicated 
parasites. Proteins were separated on SDS-
PAGE, followed by Western blot to analyze 
Irgb6 phosphorylation or the autophosphory-
lation of ROP18. For detection of phosphory-
lated or unphosphorylated Myc-Irgb6-YFP 
and Flag-tagged proteins by Western blot, 
anti-pThr, anti-Myc, and anti-Flag were used, 
respectively. (C and D) ATF6-deficient mice 
(n = 3) intraperitoneally infected with a dose 
of the indicated 102 parasites. Peritoneal fluids 
were collected at the indicated days after 
infection, and the parasite numbers were 
counted by plaque forming assays (C). CD4 or 
CD8 T cells from spleens of mice infected with 
the indicated parasites were cultured in the 
presence of 5 µg/ml plate-bound anti-CD3 for 
24 h. Concentration of IFN- in the culture 
supernatants was measured by ELISA. Indi-
cated values are means ± SD of triplicates. 
(A–D) Data are representative of two indepen-
dent experiments.JEM Vol. 208, No. 7 
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parasites  are  not  avirulent,  indicating  the  existence  of   
an  additional  ROP18-mediated  but  ATF6-independent 
virulence mechanism. N2-ROP18_F lacks 17 aa in the 
N terminus of ROP18, which corresponds to helix 2 of the 
ROP5 N-terminal extension that is essential for its localiza-
tion  to  the  PV  (Reese  and  Boothroyd,  2009).  Similarly, 
ROP18 is injected into the host cytosol during invasion and 
is ultimately found at the PV (Boothroyd and Dubremetz, 
2008).  The  N2-ROP18_F  strain  might  incapacitate 
ATF6-independent innate immune responses, including 
IRG-mediated resistance which is operative soon after the 
parasite  invasion  (Hunn  et  al.,  2008;  Zhao  et  al.,  2009; 
Khaminets et al., 2010). Indeed, ROP18 has recently been 
shown to target the member of IRGs, Irgb6 (Fentress et al., 
2010; Steinfeldt et al., 2010). In this study, we characterized 
ATF6-independent immune responses in ATF6-deficient 
mice infected with N2-ROP18_F, which inactivated Irgb6. 
Compared  with  infection  of  EMPTY  or  KD-ROP18_F, 
N2-ROP18_F infection resulted in much reduced CD4   
T cell–mediated IFN- production, suggesting that IRGs may 
be involved in activation of the ATF6-independent CD4   
T cell response. However, this assumption is contradictory to 
previous findings that the Stat1–IRG axis is not required for 
the development of Th1 immunity (Taylor et al., 2000; Collazo 
et al., 2001; Lieberman et al., 2004). This may be caused by 
strain-dependent differential host innate immune responses 
(Robben et al., 2004). Previous studies used type II parasites, 
whereas this study used type I parasites. IRG-deficient mice 
with high numbers of type II parasites are shown to culmi-
nate in higher concentrations of IL-12 in vitro and in vivo 
than that in WT mice, possibly leading to the development 
of apparently normal Th1 immunity that can compensate for 
the defect in the potential IRG-mediated CD4 T cell pheno-
type (Taylor et al., 2000; Collazo et al., 2001). Alternatively, 
the other ATF6/IRG-independent ROP18-mediated ef-
fector mechanisms may suppress the CD4 T cell response. It 
is of interest in the future to revisit the potential involvement 
of IRGs in the development of CD4 T cell response using 
relatively immune-silent but IRGs-sensitive type I rop18-KO 
or type III parasites.
Despite the CD4 T cell–mediated IFN- production and 
the successful suppression of rop18-KO parasite (Empty vector) 
increment at the early stage after infection, ATF6-deficient 
mice allowed the parasites to proliferate at the late stage and 
eventually succumbed. The CD8 T cell–mediated response is 
defective in ATF6-deficient mice. Moreover, mice defi-
cient in CD8 but not CD4 T cell functions are highly suscep-
tible to acute toxoplasmosis (Casciotti et al., 2002; Combe et al., 
2005; Lu et al., 2009). Therefore, even though the ATF6-
independent mechanism activates the CD4 T cell–mediated 
immunity that contributes to host resistance at early stages, it 
might be ultimately incompetent to counteract the acute 
parasite infection under condition of the defective CD8   
T cell responses. In contrast, considering that the rop18-KO 
parasites (Empty vector) are not as virulent as the N2-ROP18_F 
in WT mice, the ATF6-independent CD4 T cell response 
defense against pathogens (Tateda et al., 2008; Martinon et al., 
2010; Richardson et al., 2010). In this study, we report the pro-
tective effect of ATF6 against rop18-KO but not WT parasite 
infection. It remains to be determined whether ATF6 also 
participates in host defense against other pathogens and whether 
other ATF6 family members including ATF6 and Creb3 (also 
known as Luman) are targeted by ROP18 (Liang et al., 2006; 
Zhang and Kaufman, 2008).
Our data suggest that ATF6 deficiency in DCs rather 
than in T cells is responsible for the defective production of 
IFN- in CD8 T cells, yet a formal proof would require the 
conditional ablation of ATF6 in these cell types. Given that 
ATF6 acts as transcription factor, it will be important to de-
termine which of the ATF6-regulated genes mediate DC 
activation leading to CD8 T cell responses.
DCs treated with an inhibitor of the ER-associated deg-
radation (ERAD) system were shown to fail to induce CD8 
T cell response by cross-presentation (Goldszmid et al., 2009). 
The close association and possible fusion of host ER with the 
PV of T. gondii could cause an ER overload leading to ERAD 
activation (Sinai et al., 1997; Goldszmid et al., 2009). Inter-
estingly, the ATF6 family members regulate the transcription 
of a subset of ERAD components (Wu et al., 2007), so it is 
conceivable that type I virulent T. gondii strains might target 
ATF6 in DCs (or other APCs such as macrophages) to 
down-regulate UPR-meditated host defense (Blanchard and 
Shastri, 2010). The data presented in this study are consistent 
with the previous findings that (part of) host ERs fuse with 
PVs during T. gondii infection (Goldszmid et al., 2009; Melo 
et al., 2010). However, studies showing that some ER-resident 
proteins colocalized with the PVMs do not constitute direct 
evidence for the host ER–PV fusion, and thus more in depth 
analysis is required to support this model.
ATF6-deficient mice are highly susceptible to rop18-KO 
parasites with high parasite burdens possibly caused by defec-
tive IFN- responses of CD8 T cells. However, T cells from 
dying ATF6-deficient mice (for instance, at days 9–10 after 
infection), in which the spleen was about to be autodigested and 
partly adhesive to other organs, secreted extremely high con-
centrations of IFN- even under nonstimulated conditions 
(unpublished data), which is indicative of an overreacting im-
mune responses just before death. Thus, high susceptibility to the 
parasites might be primarily attributable to the excessive parasite 
proliferation and terminally dysregulated immune pathology.
Previous  studies  reported  that  ROP18-overexpressing 
parasites exhibited accelerated growth (Taylor et al., 2006;   
El  Hajj  et  al.,  2007).  In  contrast,  the  rop18-KO  parasites 
showed normal intracellular growth in this study. It is plau-
sible that overexpression of ROP18 impacts proliferation by 
acting on additional host cell substrates that are not essential 
to promote normal growth of rop18-KO parasites.
Expression of N2-ROP18_F, which lacks the ATF6-
binding region, moderately restores the virulence of rop18-KO 
parasites. Because this ROP18 mutant does not associate with 
ATF6, ATF6-mediated host defense might be functional in 
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Generation of RHhxgprt T. gondii–expressing OVA and a fusion 
protein of RFP and luciferase. To express luciferase, RFP, and OVA, we 
constructed a plasmid harboring p30-OVA and luciferase-RFP fusion pro-
teins (pOVRFPluc). The luciferase and RFP fragments were obtained by 
PCR using primers OVA_F and OVA_R, with plasmid pGL3 as the tem-
plate or primers RFP_F and RFP_R using pDsRed-express (Takara Bio Inc.) as 
the template, respectively. The information for all primers used in this study 
is listed in Table S1. The EcoRI–XhoI fragment of luciferase and the XhoI–
PacI fragment of RFP were cloned into the EcoRI–PacI-digested sag1-
ROP16HA-3UTR plasmids (Yamamoto et al., 2009). The NotI fragment 
of sag1-Luciferase/RFP-3UTR was cloned into the site of p30-OVA plas-
mids (a gift from D.S. Roos, University of Pennsylvania, Philadelphia, PA), 
leading to the generation of the OVRFPluc plasmid. 100 µg of the OVRF-
Pluc  plasmids  was  transfected  with  RHhxgprt  parasites,  and  the  stable 
transformants were selected in RPMI media containing 20 µM chloram-
phenicol (Nacalai Tesque), as p30-OVA plasmids contained a cassette for the 
chloramphenicol resistance gene (Pepper et al., 2004). RFP-positive para-
sites were selected by fluorescent microscopy and tested for in vitro and in 
vivo luciferase activity. Three clones were isolated, and we observed compa-
rable in vitro growth and in vivo virulence to each other and the parental 
line. Whether the parasite line, which was used for generation of rop18-KO 
parasites, expresses OVA has not been tested in this study.
Generation of ROP18-deficient type I T. gondii. Genomic DNA con-
taining the ROP18 gene was isolated by PCR using primers R18KOLA_F 
and R18KOLA_R to generate a 5.0-kb-long fragment. Primers R18KOSA_F 
and R18KOSA_R generated a 1.0-kb fragment. The gene encoding T. gon-
dii ROP18 consists of a single exon. The targeting vector (pKO-ROP18) 
was constructed by replacing the entire coding sequence of ROP18 with the 
HXGPRT gene expression cassette (p2855). Outside the targeting vector, a 
YFP expression vector was ligated using a NotI site for the negative selection 
of random integration. 100 µg of the targeting vector linearized by ScaI was 
transfected into tachyzoites of the normal RHhxgprt parental strain or 
OVRFPluc RHhxgprt parasites as previously described (Yamamoto et al., 
2009). After 25 µg/ml mycophenolic acid (MPA; Sigma-Aldrich) and 25 µg/ml 
xanthine (Wako Chemicals USA) selection for 14 d, MPA/xanthine-resistant 
colonies were sorted using a FACSAria (BD) to isolate YFP-negative para-
sites. The MPA/xanthine-resistant and YFP-negative parasites were sub-
jected to limiting dilution to isolate the clones. A total of 142 clones were 
selected and screened by PCR for detecting homologous recombinants 
using primers DHFRrc01 (from the DHFR promoter of the HXGPRT ex-
pression vector) and R18ex01 (genomic sequence outside the short fragment 
of the ROP18 locus), to detect homologous recombinants. This resulted in 
the isolation of four clones using normal RHhxgprt parasites and two 
homologous recombinants using OVRFPluc RHhxgprt parasites. Subse-
quently, genomic DNA of WT and ROP18-deficient parasites was extracted 
and subjected to Southern blot analysis using a DNA probe, which was gen-
erated by PCR using primers SB_F and SB_R. Additionally, to confirm the 
disruption of the gene encoding ROP18, we analyzed total RNA from WT 
and rop18-KO parasites by Northern blot using a DNA probe, which was 
generated by PCR using primers NB_F and NB_R.
Mammalian expression plasmids. The C-terminal Flag-tagged fragments 
of ROP18 lacking the N-terminal signal peptide were amplified using primers 
R18frg2common_F and R18frg2common_R. The series of ROP18 variants 
were amplified using primers R18D27frg1_F for 27, R18D240frg1_F for 
240, primers for 27N2 described in Table S1, and the common primer 
using genomic DNA from the RH strain and were ligated into the BamHI and 
NotI sites of a pcDNA vector. The kinase-inactive ROP18 mutant containing 
point mutations was generated using the primers D394A_F and D394A_R, 
and expression plasmids were generated using a site-directed mutagenesis kit 
(Agilent Technologies). The sequences of all constructs were confirmed with a 
genetic analyzer (ABI PRISM; Applied Biosystems). Human ATF6 cDNA 
was  amplified  using  primers  ATF6_full_R  for  Full,  ATF6_DC_R   
for  C, ATF6_DCDTM_R  for  CTM,  and  the  common  primer 
may considerably enhance host resistance under the normal 
CD8 T cell conditions. Previous studies established that in-
terference with the innate function of Irgb6 is an important 
mechanism of ROP18-mediated virulence especially at an 
early stage after infection (Fentress et al., 2010; Steinfeldt et al., 
2010). Furthermore, our study reveals that ROP18 also tar-
gets ATF6-dependent CD8 T cell–mediated acquired im-
mune responses that act at a later stage after infection. Thus, 
ROP18 may continue to disarm host immunity during the acute 
pathogenesis by targeting different host factors at each stage.
In conclusion, this study identifies ATF6 as a novel and 
unexpected substrate for ROP18. This finding nicely com-
plements the recently published study to establish that the 
kinase activity of ROP18 is essential for the mortality pheno-
type and may be required for the suppression of both the 
ATF6-dependent and -independent host defense mechanisms 
(Taylor et al., 2006). Interestingly, KD-ROP18_F expression 
in rop18-KO parasites appeared to reduce virulence. Because 
ROP18 belongs to the ROP2 subfamily consisting of >30 
members including 17 active kinases (Peixoto et al., 2010), it 
is possible that expression of KD-ROP18 might have a dom-
inant-negative effect, suppressing the action of other family 
members implicated in virulence. Whether other ROP2 sub-
family members are important for the type I parasite–mediated 
virulence in concert with ROP18 should be examined in 
the future. Intriguingly, type II parasites are shown to be 
avirulent  in  spite  of  normal  expression  levels  of  ROP18. 
Given that ROP16 does not act positively in the virulence 
(Saeij et al., 2006), type II parasites might be defective in other 
ROP2 subfamily members.
In summary, ATF6 has been associated in this study for 
the first time with a resistance mechanism against an intracel-
lular pathogen. ROP18, an effector molecule that constitutes 
the major virulence factor T. gondii type I strain, controls 
ATF6 degradation. In the future, the in vitro assay system 
based  on  the  UPR-containing  reporter  may  facilitate  the   
development of a new pharmaceutical drug targeting ROP18 
that can block acute toxoplasmosis.
MATERIALS AND METHODS
Cells, mice, and parasites. BALB/c and outbred CD1 ICR mice (6–8 wk 
old) were obtained from SLC. All animal experiments were conducted 
with the approval of the Animal Research Committee of the Graduate 
School of Medicine at Osaka University. RHhxgprt and its derivatives of 
T. gondii were maintained in Vero or HFFs by biweekly passage in RPMI 
(Nacalai Tesque) supplemented with 2% heat-inactivated FCS (JRH Bio-
sciences), 100 U/ml penicillin, and 0.1 mg/ml streptomycin (Invitrogen). 
The  CTG  strain  was  provided  by  D.  Sibley  (Washington  University 
School of Medicine, St. Louis, MO) and maintained in Vero cells in the 
RPMI media.
Reagents. Antibodies against T. gondii major surface antigen 1 (SAG1), 
anti-TGTP (Irgb6), anti-Myc, and HA probe were obtained from Santa 
Cruz Biotechnology, Inc. Anti-pTyr and anti-pThr were obtained from 
Cell Signaling Technology. Anti-Flag and anti-pSer were obtained from 
Sigma-Aldrich. Anti-ROP1 was provided by J.F. Dubremetz (Université de 
Montpellier  2,  Montpellier,  France).  For  indirect  immunofluorescence, 
anti-HA rat antibody was obtained from Roche. MG132 was obtained 
from EMD.JEM Vol. 208, No. 7 
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plus the human BM Mate & Plate cDNA library (Takara Bio Inc.). After the 
screening of 107 clones, we finally obtained 10 positive clones and recovered 
the pGAD library from individual clones and expanded in Escherichia coli. 
The inserted cDNA was sequenced and characterized with the BLAST pro-
gram, resulting in the identification of ATF6 (nine clones) and HLA-DPA1 
(one clone). Because the number of positive clones of ATF6 was much 
greater than that of HLA-DPA1 and because HLA-DPA1 was difficult to be 
linked to the mouse homologue correctly compared with ATF6, we selected 
ATF6 in the following study.
Luciferase reporter assay. The 5× UPRE luciferase reporter was gener-
ated by the synthesis of a 312-bp fragment containing five tandem ATF6 
binding sites (Invitrogen), with the MluI–SalI fragment inserted into the 
MluI–XhoI  site  of  the  pGL3  luciferase  reporter  as  described  previously   
(Wu et al., 2007; Yamamoto et al., 2007). The reporter plasmids were tran-
siently cotransfected into 293T cells with the control Renilla luciferase ex-
pression vectors using Lipofectamine 2000 reagent (Invitrogen). Luciferase 
activities of total cell lysates were measured using the Dual-Luciferase 
Reporter Assay System (Promega) as described previously (Yamamoto   
et al., 2006).
Statistical analysis. The unpaired Student’s t test was used to determine 
statistical significance among experimental data.
Measurement of IFN- by ELISA. CD4 and CD8 T cells were obtained 
by positive selection using anti-CD4 (L3T4) and anti-CD8a (Ly-2) magnetic 
beads (Miltenyi Biotech) from splenocytes of mice at day 6 after infection 
with parasites and cultured for 24 h in 96-well plates (105 cells per well) pre-
coated with 5 µg/ml anti-CD3 or preincubated with 105 BM-derived DCs 
(BMDCs) pulsed with heat-killed T. gondii antigens, which were prepared 
by incubation of 107 parasites at 56°C for 1 h. For the generation of BMDCs, 
BM cells were isolated from femurs and cultured with RPMI 1640 supple-
mented with 10% fetal bovine serum and 10 ng/ml GM-CSF (PeproTech) 
with medium replaced every 2 d. Concentration of IFN- in the culture 
supernatant was measured by ELISA according to the manufacturer’s instruc-
tions (R&D Systems), as described previously (Yamamoto et al., 2003).
Western blot analysis and immunoprecipitation. The 293T cells and 
parasites were lysed in a lysis buffer (1% Nonidet P-40, 150 mM NaCl, and 
20 mM Tris-HCl, pH 7.5) containing a protease inhibitor cocktail (Roche). 
The cell lysates were separated by SDS-PAGE and transferred to polyvinyli-
dene fluoride membranes. For immunoprecipitation, cell lysates were pre-
cleared with protein G–Sepharose (GE Healthcare) for 2 h and then incubated 
with protein G–Sepharose containing 1.0 µg of the indicated antibodies for 
12 h with rotation at 4°C. The immunoprecipitants were washed four times 
with lysis buffer and eluted by boiling with Laemmli sample buffer. The elu-
ates were separated by SDS-PAGE, transferred to polyvinylidene fluoride 
membranes, and subjected to Western blot analysis as described previously 
(Yamamoto et al., 2004).
Flow cytometric analysis. 2 × 106 splenocytes were stained with PE-
conjugated anti-B220, -CD8, or -CD11c, FITC-conjugated anti-CD3 or 
-CD4, and APC-conjugated anti-Gr1. Stained cells were analyzed on a 
FACSCantoII (BD) and using FlowJo Software (Tree Star).
Microscopic analysis. The 293T cells were transfected with 2 µg of ex-
pression vectors for HA_ATF6_YFP-T2ACFP–tagged KDROP18_Flag 
or ER-DsRed. At 24 h after transfection, cells were analyzed using a fluo-
rescence microscope (IX71; Olympus).
Immunofluorescence  analysis. HFF cells infected with parasites were 
fixed for 8 min in PBS containing 4% paraformaldehyde (PFA)/0.05% glu-
taraldehyde. Cells were permeabilized with PBS containing 0.2% Triton X-100 
(PBS/TX) and then blocked with 2% BSA in PBS/TX. Subsequently, cells 
were incubated with anti-Rop1 rabbit antibody (1:200) and anti-Flag mouse 
ATF6_common_F using human BM cDNA as the template and then li-
gated into the EcoRI and NotI sites of a pcDNA vector for the N-terminal 
HA-tagged proteins (Invitrogen). Murine Irgb6 cDNA was amplified using 
primers Irgb6_F and Irgb6_R using IFN-–treated mouse macrophage cDNA 
as the template and then ligated into the EcoRI and XhoI sites of a pcDNA 
vector for the N-terminal HA-tagged and C-terminal YFP-tagged proteins. 
To express HA-hATF6 and CFP bicistronically using a self-cleavage T2A 
peptide (Holst et al., 2006), an expression vector for HA-hATF6_T2ACFP 
was generated by ligation with a pcDNA vector for the N-terminal HA and 
EcoRI–XhoI fragment of hATF6, which was generated by PCR using 
primers ATF6_common_F and ATF6_full_XhoI_R. T2ACFP was gener-
ated by PCR using primers T2ACFP_R and T2ACFP_F using a CFP vector 
as the template. The expression vector for HA_hATF6_YFP-T2ACFP_
KDROP18_Flag was constructed by cloning the EcoRI–XhoI fragment of 
hATF6. The SalI–SacI fragment of YFP was amplified using primers YFP_F 
and YFP_R, using a YFP vector as the template. The SacI–BamHI fragment 
of T2ACFP and the BamHI–NotI fragment of KD-ROP18-Flag were in-
serted into the EcoRI–NotI site of the pcDNA vector for the N-terminal HA 
tag. By placing the T2A peptide between HA-hATF6 (or HA-hATF6-
YFP) and CFP (or CFP-KD-ROP18-Flag), we obtained independent and re-
liable expression of both proteins. The ER-localizing RFP vector pDsRed2-ER 
was purchased from Takara Bio Inc.
Generation of transgenic parasites. To complement the rop18-KO para-
sites, we generated an N-terminal signal peptide–containing ROP18, ca-
pable  of  being  processed  in  the  parasite,  by  PCR  using  the  primer 
ParasiteR18frg1_F for ROP18-Flag (ROP18_F) or KD-ROP18_F and ex-
pressed the ROP18-F proteins driven by the sag1 promoter containing a 
pyrimethamine resistant gene cassette in the rop18-KO strain (Yamamoto 
et al., 2009). N2-ROP18 lacking residues 147–164 of the N-terminal portion 
was generated by ligation of two fragments: one from the EcoRI–NotI frag-
ment of ROP18_F and the other generated using primers ParasiteR18frg1F, 
DN2(HX2)_F, and DN2(HX2)_R. We generated this vector by digest-
ing the pyrimethamine resistance cassette of the p2854 plasmid with NotI 
and XhoI and ligated this into a Klenow-treated pBluescript sag1-ROP18_F 
vector. A series of ROP18_F vectors or the empty p2854 vector for the 
generation of the Empty vector strain were transfected into tachyzoites of the 
rop18-KO parasites. We selected for parasites stably expressing the comple-
mented ROP18_F constructs using 3 µM pyrimethamine (Sigma-Aldrich) 
selection and subjected these to limiting dilution as described previously 
(Yamamoto et al., 2009).
Generation  of  ATF6-deficient  mice. The Atf6 gene was isolated 
from genomic DNA extracted from embryonic stem cells (V6.5) by PCR 
using LA Taq (Takara Bio Inc.). The targeting vector (pKOATF6) was 
constructed by replacing a 3.0-kb fragment encoding the exons of ATF6 
with a neomycin-resistance gene cassette (neo) and a herpes simplex virus 
thymidine kinase gene driven by the PGK promoter, for negative selection. 
Genomic DNA containing the murine Atf6 gene was isolated by PCR 
amplification using primers ATF6KO_LA_F and ATF6KO_LA_R to 
generate a 5.0-kb fragment or primers ATF6KO_SA_F and ATF6KO_
SA_R to generate a shorter 1.0-kb fragment. After the targeting vector was 
transfected into embryonic stem cells, colonies resistant to both G418 and 
ganciclovir were selected and screened by PCR and Southern blotting. 
Homologous recombinants were microinjected into C57BL/6 female mice, 
and heterozygous F1 progenies were intercrossed to obtain ATF6-deficient 
mice. ATF6-deficient mice and their WT littermates from these inter-
crosses were used for experiments.
Yeast two-hybrid analysis. Yeast two-hybrid screening was performed as 
described with the Matchmaker two-hybrid system (Takara Bio Inc.). For 
construction of the bait plasmid, the cDNA fragment coding the N-terminal 
portion (aa 35–235) of ROP18 was amplified using primers ROP18Y2H_F 
and ROP18Y2H_R and cloned in frame into the GAL4 DNA-binding do-
main of pGBKT7. Yeast strain AH109 was transformed with the bait plasmid 1544 ATF6 is a host target of Toxoplasma ROP18 | Yamamoto et al.
and subjected to Western blot to detect unphosphorylated or phospho-GST–
tagged ATF6 and Flag-tagged ROP18WT, ROP18KD, or ROP16WT 
by anti-GST, anti-pThr, anti-pSer, anti-pTyr, and anti-Flag, respectively.
Immunological experiments. To assess the phenotype in T cells (Fig. 6 E), 
DCs were generated from BMs of two WT mice cultured in GM-CSF. 
2 × 107  DCs were collected at day 6 after cultivation and infected with irra-
diated rop18-KO parasites at multiplicity of infection (MOI) = 1 for 12 h. 
The cells were collected at 1,100 rpm and extensively washed with PBS 
three times at 4°C. 1,000,000 DCs were intraperitoneally injected into the 
littermates of WT or ATF6-deficient mice (n = 2 for each group; n = 4 
total for two independent experiments). 6 d after injection, CD4 or CD8   
T cells were isolated by the positive selection of splenic T cells. The T cells 
(105 cells) were co-cultured with WT DCs (5 × 104 cells), which were 
freshly isolated from the littermate WT mouse and cultivated for 6 d in the 
presence of GM-CSF and uninfected or infected with irradiated rop18-KO 
parasites for 12 h at MOI = 1 for 48 h. The supernatants were collected and 
tested for ELISA to measure the IFN- concentration.
To analyze the phenotype of DCs for the ability of IFN- produc-
tion from T cells (Fig. 6 F), CD4 and CD8 T cells were isolated from 
WT mice infected with 103 rop18-KO parasites 6 d after the infection. 
The T cells (105 cells) were co-cultured with DCs (5 × 104 cells), which 
were freshly isolated from the littermate WT or ATF6-deficient mice 
(n = 2 for each group; n = 4 total for two independent experiments), and 
cultivated for 6 d in the presence of GM-CSF and uninfected or infected 
with irradiated rop18-KO parasites for 12 h at MOI = 1 for 48 h. The   
supernatants  were  collected  and  tested  for  ELISA  to  measure  the   
IFN- concentration.
Quantification of parasite loads. The parasites in the peritoneal cavities 
were enumerated as described previously (Robben et al., 2005). In brief, 
total peritoneal contents were collected by injection of 5 ml of FCS-free 
RPMI into the peritoneal cavities of infected mice. Aliquots of the recov-
ered fluids were added onto confluent monolayer of mouse embryonic 
fibroblasts in 96-well culture plates with 10-times serial dilutions from 100 to 
105 and 4 wells of each dilution. 4 d after infection, the numbers of plaques 
were counted to calculate the total parasite numbers in the original perito-
neal cavities.
Online supplemental material. Fig. S1 shows parasitological analysis of 
rop18-KO type I T. gondii. Fig. S2 demonstrates complementation of rop18-
KO parasites by various ROP18 mutants. Fig. S3 exhibits splenic cellularity 
in mice infected with WT or rop18-KO parasites. Fig. S4 shows specific in-
teraction of Nt-ROP18 with ATF6 in yeasts and similar infection levels be-
tween WT and rop18-KO parasites in 293T cells. Fig. S5 demonstrates ER 
localization of ROP18 and PVM–ER fusion. Fig. S6 describes the strategy 
for generation of ATF6-deficient mice and shows comparable susceptibility 
in WT or ATF6-deficient mice infected with WT T. gondii. Table S1 pro-
vides a list of the primers used in this study. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20101660/DC1.
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antibody (1:6,000; Sigma-Aldrich) for 1 h at room temperature, followed by 
incubation with Alexa Fluor 488–conjugated goat anti–rabbit IgG antibody 
(Invitrogen) and Alexa Fluor 594–conjugated goat anti–mouse IgG antibody 
(Invitrogen) for 45 min at room temperature in the dark. Finally, the immuno-
stained cells were mounted with Fluoromount-G (SouthernBiotech) on glass 
slides and analyzed using a fluorescence microscope (Axioskop 2; Carl Zeiss) 
equipped  with  a  color  charge-coupled  device  camera  (Axiocam  HR; 
Carl Zeiss).
Plaque assay. The WT and rop18-KO parasites were used to infect mono-
layers of HFFs seeded in 24-well plates. After incubation for 8–9 d at 37°C, 
cells were fixed with 4% PFA and 0.05% glutaraldehyde in PBS, followed by 
staining with Giemsa for 10 min.
Assessment of intracellular growth. Host cells seeded on 24-well im-
munofluorescence assay plates were inoculated with freshly released WT or 
rop18-KO parasites. At 24 h after infection, parasites were fixed with 4% 
PFA. Immunofluorescence assays were performed using -TgGAP45 anti-
body, and parasites were counted on at least 100 vacuoles for each strain.
Electron microscopy analysis. Monolayers of HFFs were infected with 
rop18-KO parasites. Samples were collected at 4 h after infection and pro-
cessed for electron microscopy using routine techniques. In brief, parasite 
pellets were fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer, post-
fixed in osmium tetroxide, dehydrated in ethanol, and treated with propylene 
oxide before embedding in Spurr’s epoxy resin. Thin sections were stained 
with uranyl acetate and lead citrate before examination with an electron 
microscope (1200EX; JEOL).
In vivo imaging analysis. Mice were intraperitoneally infected with 103 
freshly egressed tachyzoites resuspended in 100 µl PBS, with assessment of 
bioluminescence performed on the indicated days after infection. For the 
detection of bioluminescence emission, mice were intraperitoneally injected 
with 3 mg d-luciferin in 200 µl PBS (Promega), maintained for 5 min to 
allow for adequate dissemination of luciferin, and subsequently anaesthetized 
with isoflurane (Dainippon Sumitomo Pharma). At 10 min after injection of 
d-luciferin, photonic emissions were detected using an in vivo imaging sys-
tem (IVIS 100; Xenogen) and Living image software (Xenogen).
Recombinant  ATF6  purification.  GST-tagged  ATF6  cDNA  was 
subcloned into pFAST-Bac (Invitrogen) for expression in Sf9 insect cells. 
Proteins were purified in accordance with the manufacturer’s instruction as 
described previously (Yamamoto et al., 2006).
In vitro kinase assay. 5 × 106  293T cells (6-cm dish) were transiently 
transfected with a total of 4 µg of either empty vector or the indicated plas-
mids (4 µg of Flag-tagged ROP18WT, ROP18KD, or ROP16WT), using 
Lipofectamine 2000 as specified by the manufacturer. Cells were harvested 
24 h after transfection, lysed, and then immunoprecipitated with protein G–
Sepharose together with 1.0 µg anti-Flag M2 mAb (Sigma-Aldrich) for 12 h 
by rotation. The beads were washed four times with lysis buffer and another 
three times with kinase assay buffer (30 mM MOPS, pH 7.5, 50 mM NaCl, 
10% glycerol, 10 mM MgCl2, and 10 mM MnCl2). The immunoprecipitates 
were  incubated  with  1  µg  GST-ATF6  and  10  mCi  -[32P]ATP  (GE 
Healthcare) or 5 µM cold ATP (Wako Chemicals USA) to phosphorylate 
GST-ATF6, ROP18WT, ROP18KD, or ROP16WT at 30°C for 30 min. 
In the experiments for Fig. 7 B, immunoprecipitates of the parasites comple-
mented with the ROP18 variants, which were prepared by immunoprecipi-
tation of the parasite lysates by anti-Flag, were incubated with anti-myc 
immunoprecipitates of 293T cells transfected with control- or Myc-tagged 
Irgb6-YFP fusion vectors in the presence with 5 µM cold ATP in the kinase 
reaction buffer at 30°C for 30 min with gentle agitation. Kinase reactions 
were stopped by the addition of Laemmli sample buffer and were separated 
on a 5–20% polyacrylamide gradient gel. For radioactive samples, gel was de-
tained, dried, and exposed to x-ray film. For cold samples, gel was detained JEM Vol. 208, No. 7 
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